Zantac Generics MDL Labeling Claims Axed As Preempted

By Dorothy Atkins (January 4, 2021, 4:44 PM EST) -- A Florida federal judge presiding over sprawling multidistrict litigation over the carcinogens found in the popular heartburn medication Zantac has held that state labeling and design defect claims against Zantac generics makers, repackagers, retailers and distributors are preempted by federal law....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!